All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
XILIO THERAPEUTICS, INC. Last Reported: 4/30/2024 Stock Symbol: XLO

Business Address

828 WINTER STREET

WALTHAM , MA US 02451

Mailing Address

828 WINTER STREET

WALTHAM , MA US 02451
Phone Number: 617-833-1027 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Cash and Cash Equivalents $44,700,000.00 $59,772,000.00 $75,383,000.00 $93,300,000.00 $120,385,000.00 $139,143,000.00 $159,400,000.00 $176,959,000.00 $198,100,000.00 $99,800,000.00 -- -- $19,238,000.00 -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $3,423,000.00 $4,708,000.00 $3,042,000.00 $3,705,000.00 $4,111,000.00 $3,171,000.00 $3,597,000.00 $4,128,000.00 $4,464,000.00 -- -- -- -- -- -- -- --
Total Current Assets $48,127,000.00 $64,480,000.00 $78,425,000.00 $96,976,000.00 $124,496,000.00 $142,314,000.00 $163,007,000.00 $181,087,000.00 $202,517,000.00 $105,572,000.00 -- -- $20,590,000.00 -- -- -- --
Property Plant and Equipement $5,942,000.00 $6,366,000.00 $6,798,000.00 $7,252,000.00 $7,255,000.00 $7,553,000.00 $7,442,000.00 $7,468,000.00 $7,620,000.00 $7,108,000.00 -- -- $7,367,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $145,000.00 $169,000.00 $197,000.00 $232,000.00 $267,000.00 $301,000.00 $335,000.00 $359,000.00 $393,000.00 $427,000.00 -- -- $500,000.00 -- -- -- --
Total Assets $60,926,000.00 $77,842,000.00 $92,359,000.00 $111,505,000.00 $139,165,000.00 $157,414,000.00 $178,127,000.00 $196,352,000.00 $218,060,000.00 $120,725,000.00 -- -- $36,317,000.00 -- -- -- --
Accounts Payable $1,050,000.00 $1,486,000.00 $945,000.00 $2,013,000.00 $3,125,000.00 $1,810,000.00 $1,410,000.00 $2,324,000.00 $3,144,000.00 $3,822,000.00 -- -- $5,444,000.00 -- -- -- --
Accrued Liabilities $10,497,000.00 $9,404,000.00 $7,140,000.00 $6,483,000.00 $10,327,000.00 $9,062,000.00 $12,087,000.00 $7,323,000.00 $8,751,000.00 $8,194,000.00 -- -- $13,732,000.00 -- -- -- --
Total Current Liabilities $24,099,000.00 $25,344,000.00 $24,982,000.00 $26,713,000.00 $33,518,000.00 $31,116,000.00 $33,910,000.00 $30,231,000.00 $32,631,000.00 $34,292,000.00 -- -- $41,602,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-325,500,000.00 $-307,900,000.00 $-291,100,000.00 $-271,754,000.00 $-249,108,000.00 $-226,642,000.00 $-206,852,000.00 $-182,239,000.00 $-160,886,000.00 $-141,185,000.00 -- -- $-85,086,000.00 -- -- -- --
Total Stockholders' Equity $36,827,000.00 $52,498,000.00 $67,377,000.00 $84,792,000.00 $105,647,000.00 $126,298,000.00 $144,217,000.00 $166,121,000.00 $185,429,000.00 $-136,455,000.00 $-121,309,000.00 $-99,137,000.00 $-83,287,000.00 $-63,034,000.00 $-48,904,000.00 $-37,545,000.00 $-29,523,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $60,926,000.00 $77,842,000.00 $92,359,000.00 $111,505,000.00 $139,165,000.00 $157,414,000.00 $178,127,000.00 $196,352,000.00 $218,060,000.00 $120,725,000.00 -- -- $36,317,000.00 -- -- -- --

Statement of Operations

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $52,136,000.00 $40,400,000.00 $29,349,000.00 $16,131,000.00 $59,201,000.00 $44,204,000.00 $31,166,000.00 $14,920,000.00 $51,188,000.00 $39,836,000.00 -- -- -- $11,460,000.00 -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $79,133,000.00 $17,361,000.00 $43,642,000.00 $23,526,000.00 $89,149,000.00 $65,982,000.00 $45,776,000.00 $21,224,000.00 $75,044,000.00 $55,488,000.00 -- -- -- $33,968,000.00 -- -- --
Loss from Operations $-79,133,000.00 $-61,003,000.00 $-20,116,000.00 $-23,526,000.00 $-89,149,000.00 $-65,982,000.00 $-45,776,000.00 $-21,224,000.00 $-75,044,000.00 $-55,488,000.00 -- -- -- $-33,968,000.00 -- -- --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-2.78 $-0.61 $-1.53 $-0.83 $-3.22 $-2.40 $-1.68 $-0.78 $-13.52 $-76.18 -- -- -- $-24.19 -- -- --
Weighted Average Shares Basic 27,496,107 27,475,579 27,468,668 27,433,252 27,392,087 27,399,906 27,384,614 27,367,377 5,606,308 763,869 -- -- -- 612,657 -- -- --
Earnings Per Share Diluted $-2.78 $-2.14 $-1.53 $-0.83 $-3.22 $-2.40 $-1.68 $-0.78 $-13.52 $-76.18 -- -- -- $-72.02 -- -- --
Weighted Average Shares Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 220,400,000 -- -- 126,000,000 -- -- -- --
Common Stock Shares Outstanding 27,607,646 27,528,926 27,518,895 27,439,820 27,425,447 27,407,149 27,391,834 27,376,473 27,358,375 778,949 -- -- 689,929 -- -- -- --
Common Stock Value $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00 -- -- -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com